Abilify Gambling Lawsuit Alleges Failure To Warn About Compulsive Gambling Behavior

Print

Abilify Gambling Lawsuit Filings Contend Plaintiffs Suffer Economic, Physical, And Mental Injuries Due To Impulse Control Disorders Caused By Abilify.

abilify-compulsive-gambling-lawsuit-side-effects-lawsuits-bottleAccording to a recently filed Abilify gambling lawsuit, A Texas man began compulsive gambling and spending after he was prescribed Abiify five years ago. However, it wasn’t until 2016 that he discovered the compulsive behavior that led to his mental, physical and financial losses was due to Abilify, the complaint contends.The Abilify lawsuit mirrors other federal Abilify gambling complaints that allege plaintiffs develop compulsive behavior problems after taking the Abilify antipsychotic medication.

The Texas man was prescribed Abilify in 2011, and at that time, the medication’s safety label in the United States did not warn about the risk of pathological gambling, according to the lawsuit filed in December that names Otsuka Pharmaceuticals and Bristol-Myers Squibb as defendants. However, Abilify’s safety label in Europe and Canada warned about the pathological gambling risk. The complaint asserts the defendants did not warn Abilify’s U.S. prescribers about the risk of compulsive behaviors until January 2016. As a result of the failure to warn, the plaintiff said he suffered neuropsychiatric and physical injury, emotional distress, harm, and economic loss. His urges to gamble have decreased after he stopped taking Abilify, the complaint said. (Case No. 3:2017cv00002, In Re: Abilify (Aripiprazole) Products Liability Litigation – MDL 2734)

“Abilify can devastate men and women physically, mentally and financially. Our firm works tirelessly on behalf of those who have suffered harm due to taking this drug,” says Wright & Schulte.

The firm is offering free Abilify gambling lawsuit evaluations to individuals who allegedly sustained significant financial losses and other damages due to an Abilify gambling addiction or other impulse control problems that may be linked to the medication. Please visit our website at www.yourlegalhelp.com or call 1-800-399-0795 to learn more about your potential legal recourse.

Abilify (aripiprazole) is an atypical antipsychotic drug approved by the U.S. Food and Drug Administration (FDA) in November 2002 to treat schizophrenia, bipolar disorder, Tourette’s disorder, and irritability associated with autistic disorder. The drug is also used with antidepressants to treat depression. Aripiprazole is in a class of medications called partial dopamine receptor agonists and works somewhat differently than other medicines in its class, according to the FDA, Most atypical antipsychotics more fully block dopamine receptors in the brain, while aripiprazole only partially blocks the activity of these receptors. The drug is marketed under the brand names Abilify, Abilify Maintena, Aristada, and also as generics.
[fda.gov/Drugs/DrugSafety/ucm498662.htm, FDA, May 3, 2016]

In May, the FDA added a new warning about compulsive behaviors to the drug labels and the patient Medication Guides for all aripiprazole products. While pathological gambling was already listed as a side effect, the drug labels did not list uncontrollable urges to binge eat, shop, and have sex. These behaviors were added to the labels. Since Abilify was approved in 2002, the FDA said that it had received 184 reports of compulsive behaviors that include gambling, eating, spending, shopping and sex.

Court documents indicate that plaintiffs involved in Abilify gambling lawsuits asked the U.S. Panel on Multidistrict Litigation to consolidate all federal Abilify gambling complaints. In October, the federal judicial panel granted their request and centralized the Abilify complaints for coordinated pretrial proceedings in the U.S. District Court, Northern District of Florida. All of the federal Abilify lawsuit claims contend that Otsuka Pharmaceuticals and Bristol-Myers Squibb, which makes and markets Abilify, did not adequately warn doctors and their patients that the medication allegedly causes compulsive behaviors. (In Re: Abilify (Aripiprazole) Products Liability Litigation – MDL 2734)

Wright & Schulte LLC And Filing An Abilify Gambling Lawsuit

Wright & Schulte LLC is an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, do not hesitate to contact Wright & Schulte LLC today. Free Abilify gambling lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Contact:
Wright & Schulte LLC
865 S. Dixie Dr.
Vandalia, Ohio 45377
1-800-399-0795
www.yourlegalhelp.com

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.